Ashland has announced that its Calvert City, Kentucky, facility has earned EXCiPACTTM certification for Good Manufacturing Practice (GMP). Its scope covers the manufacturing, testing and packaging of polyvinylpyrrolidone (PVP) and polyvinylpolypyrrolidone (PVPP) used as pharmaceutical excipients. According to EXCiPACT, the certifying body, this is the first U.S. excipient facility to receive certification.
Ashland has established a goal of having all of its global pharmaceutical excipient facilities certified by 2017. A leader in excipients, Ashland supplies both cellulosic and polyvinylpyrrolidone polymers to the pharmaceutical industry, along with dedicated technical expertise and support.
“This achievement reflects Ashland’s commitment to providing high-quality products and services to our customers,” said Annie Tannhauser, vice president global product regulatory and quality, Ashland. “As an industry leader, we are always challenging ourselves to be the best in the products we produce and the quality approach we use to do so.”
“The transparency and global reach of this certification program will further patient safety through consistent, global quality standards,” noted Deneen Law, global pharmaceutical marketing and innovation director, Ashland.